- Home
- PVLA vs GRC Comparison
PVLA vs GRC Comparison
Compare PVLA & GRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PVLA | GRC |
|---|---|---|
| Founded | 2015 | 1933 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Fluid Controls |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.1B |
| IPO Year | 2013 | 1994 |
Fundamental Metrics
Financial Performance| Metric | PVLA | GRC |
|---|---|---|
| Price | $150.33 | $77.58 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 15 | 0 |
| Target Price | ★ $171.87 | N/A |
| AVG Volume (30 Days) | ★ 154.3K | 143.6K |
| Earning Date | 05-12-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 1.04% |
| EPS Growth | ★ 52.62 | 32.03 |
| EPS | N/A | ★ 1.41 |
| Revenue | $42,810,000.00 | ★ $682,389,000.00 |
| Revenue This Year | N/A | $6.62 |
| Revenue Next Year | $104,350.18 | $4.66 |
| P/E Ratio | ★ N/A | $55.05 |
| Revenue Growth | ★ 65.28 | 3.44 |
| 52 Week Low | $49.81 | $41.85 |
| 52 Week High | $161.38 | $92.78 |
Technical Indicators
Market Signals| Indicator | PVLA | GRC |
|---|---|---|
| Relative Strength Index (RSI) | 55.79 | 42.56 |
| Support Level | $109.68 | $75.97 |
| Resistance Level | $160.07 | $79.02 |
| Average True Range (ATR) | 7.65 | 2.33 |
| MACD | -0.53 | -0.37 |
| Stochastic Oscillator | 72.91 | 15.73 |
Price Performance
Historical ComparisonAbout PVLA Palvella Therapeutics Inc.
Palvella Therapeutics Inc is a clinical-stage biopharmaceutical company whose vision is to become the rare disease biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare skin diseases and vascular malformations for which there are no FDA-approved therapies. Its product candidate, QTORIN 3.9% rapamycin anhydrous gel, is currently in clinical development for microcystic lymphatic malformations and cutaneous venous malformations. It operates in single segment.
About GRC Gorman-Rupp Company (The)
Gorman-Rupp Co designs, manufactures, and globally sells pumps & pump systems for use in water, wastewater, construction, dewatering, industrial, petroleum, original equipment, agriculture, fire protection, heating, ventilating & air conditioning, military, and other liquid-handling applications. It operates in one business segment, the manufacture & sale of pumps and pump systems, and generates revenue from the same. Geographically, it generates the majority of its revenue from the United States.